Publications by authors named "Basem William"

Claim this Profile
A
A Phase I Study of Blinatumomab/Lenalidomide in Relapsed/Refractory B cell Lymphoma; Toxicity, Efficacy and Correlative Analysis.
Joseph M Tuscano, Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Basem William

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.
Meera Gupta, Michelle L Schoettler, Gabriel Orozco, Ruta Brazauskas, Stephanie Bo-Subait, Basem M William

Transplantation· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study.
Meera Gupta, Michelle L Schoettler, Ruta Brazauskas, Stephanie Bo-Subait, Gabriel Orozco, Basem M William

Transplantation· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narrowing of the Racial Disparities Gap in Survival of Patients With Mycosis Fungoides: A Longitudinal Analysis of the SEER Database.
Britney Le, Noha Soror, Hamid D Ismail, Mohammed Baker, Salman Abu Shetayyah, Basem M William

Clin Lymphoma Myeloma Leuk· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chronic graft--host disease on non-relapse mortality and survival.
Justin Jiang, Audrey M Sigmund, Qiuhong Zhao, Patrick Elder, Sumithira Vasu, Basem William

Leuk Lymphoma· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help.
Kevin J Curran, Sarah Nikiforow, Carlos Bachier, Yen-Michael Hsu, David Maloney, Basem William

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies.
Philip G Woost, Basem M William, Brenda W Cooper, Masumi Ueda Oshima, Folashade Otegbeye

Cytometry B Clin Cytom· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age is No Barrier: CAR-T Therapy in Older Adults.
Joseph E Maakaron, Basem M William

Drugs Aging· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.
Julio C Chavez, Francine M Foss, Basem M William, Jonathan E Brammer, Sonali M Smith

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Basem M William

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Caron A Jacobson, Julio C Chavez, Alison R Sehgal, Basem M William, Javier Munoz

Lancet Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Andrew Schaefer, Ying Huang, Adam Kittai, Joseph E Maakaron, Caner Saygin, Basem M William

Cancer Manag Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma.
Jonathan E Brammer, Zachary Braunstein, Aashish Katapadi, Kyle Porter, Michael Biersmith, Basem M William

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Axicabtagene Ciloleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma.
Allison Grana, Natalia Gut, Kiersten Williams, Joseph Maakaron, Kyle Porter, Basem M William

Clin Lymphoma Myeloma Leuk· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS.
Brendan Rasor, Tyler Dickerson, Qiuhong Zhao, Patrick Elder, Jonathan E Brammer, Basem William

Leuk Lymphoma· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies.
Jordon L Jaggers, Smith Giri, Heidi D Klepin, Tanya M Wildes, Rebecca L Olin, Basem William

J Geriatr Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation.
Nidhi Sharma, Qiuhong Zhao, Bin Ni, Patrick Elder, Marcin Puto, Basem M William

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Cutaneous T-Cell Lymphomas.
Catherine G Chung, Basem M William

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplant in first remission for transformed indolent non-Hodgkin lymphoma: additional data to guide practice.
John C Reneau, Basem M William

Br J Haematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, Jeffrey Barnes, Stefan K Barta, Basem M William

J Natl Compr Canc Netw· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Scott R Solomon, Andrew St Martin, Mei-Jie Zhang, Karen Ballen, Asad Bashey, Basem M William

Biol Blood Marrow Transplant· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome.
Adam S Kittai, David A Bond, Basem William, Ayman Saad, Sam Penza

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
Sairah Ahmed, Nilanjan Ghosh, Kwang W Ahn, Manoj Khanal, Carlos Litovich, Basem William

Br J Haematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Annie Im, Armin Rashidi, Tao Wang, Michael Hemmer, Margaret L MacMillan, Basem William

Biol Blood Marrow Transplant· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, Jeffrey Barnes, Basem M William

J Natl Compr Canc Netw· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis